A Safer Blood Thinner? 

This novel blood clot treatment doesn't increase bleeding risk

Health & Lifestyle
212

Listen to article (english)

Translate to Spanish or other 102 languages!

Future blood thinners may no longer increase the risk of bleeding if further studies confirm the potential of a new compound. Image for illustration purposes
Future blood thinners may no longer increase the risk of bleeding if further studies confirm the potential of a new compound. Image for illustration purposes

Medical News Today

- Advertisement -
  • While anticoagulants are important for preventing dangerous blood clots, they increase the risk of excessive bleeding.
  • Future blood thinners may no longer increase the risk of bleeding if further studies confirm the potential of a new compound.
  • Rather than target all clotting pathways to prevent thrombosis, the new compound strategically targets just one, so clotting continues but without a bleeding risk or toxicity.

Anticoagulants, or blood thinners, break down and prevent blood clots, semi-solid clumps of blood cells, and other substances that can block blood flow. However, anticoagulants can do their job too well, preventing clotting altogether and resulting in excessive external or internal bleeding.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/blood-thinner-potential-blood-clot-treatment-lower-bleeding-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-05-02&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Hispanic People – Especially Men – Are Less Likely to See a Doctor
Next article
Why Young Women Have More Adverse Outcomes After a Heart Attack Than Young Men

More Articles

STHS Behavioral’s Summer Mental Health Tips for Kids

STHS Behavioral urges families to prioritize emotional well-being by maintaining routines, encouraging social connections and fostering growth beyond the classroom.

New Insight Into the Iron-Retention Strategies of Colorectal Cancer Cells

Mega Doctor News by Michigan Medicine - University of Michigan Newswise — ANN ARBOR, Michigan...

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -